慢性胰腺炎药物治疗进展
被引量:1
Advance on drug therapy of chronic pancreatitis
摘要
慢性胰腺炎(chronic pancreatitis,CP)为胰腺慢性、复发性炎症,是以胰腺结构和(或)功能的进行性损害最终导致胰腺内、外分泌功能丧失为特点的病变.本文就其病因(发病机制)、临床特点、尤其是药物治疗进展综述如下.
出处
《临床药物治疗杂志》
2004年第5期42-45,39,共5页
Clinical Medication Journal
参考文献15
-
1[1]Mergener K, Baillie J. Chronic pancreatitis. Lancet, 1997, 350(9088) : 1379~1385
-
2[2]Noone PG, Knowles MK. Pancreatitis: Mutations in the PSTI gene associated with pancreatitis, Gene Therapy Weekly, 2001Dec, 27:19
-
3[3]Batra S. Chronic relapsing pancreatitis. Clinical Pediatrics, 2001,40 (2) :99~100
-
4[4]Lipoprotein lipase disease: Efficacy of gene therapy cofirmed in second animal model. Drug Week, 2003 Dec, 26:285
-
5[5]Sebastiano PD, Di Mola FF, Bockman DE, et al. Chronic pancreatitis: The perspective of pain generation by neuroimmune interaction. Gut, 2003, 52 (6), 907
-
6[6]Koliopanos A, Friess H, Kleeff J, et al. Cyclooxygenase 2 expression in chronic pancreatitis: Correlation with stage of the disease and diabetes mellitus. Digestion, 2001, 64 (4): 240~247
-
7[7]Pelletier JM, Lajeunesse D, Reboul P, et al. Therapeutic role of dual inhibitors of 5-LOX and COX selective and non-selective non steroidal anti-inflammatory drugs. Annals of the Rheumatic Disease, 2003, 62 (6) :501
-
8[8]Bornman PC, Beckingham IJ. Chronic pancreatitis. BMJ, 2001,322 (7287): 660~663
-
9[9]Banerjee B, Bagchi D. Beneficial effects of a novel IH636 grape seed proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion, 2001, 63 (3) :203~206
-
10[10]Chronic Pancreatitis: Lovastatin and other statins may stop stellate cell fibrosis. Drug Week, 2003 Jul, 18:74
二级参考文献22
-
1Valderrama R, Navarro S, Lopez JM, et al. Synthesis and degradation of collagen in pancreatic fibrogenesis. Pancreas,1999, 18( 1 ): 34-38
-
2Bachem MG, Schneider E, Gross H, et al. Identification, cul-ture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology, 1998,115(2):421-432
-
3Apte MV, Haber PS, Darby SJ, et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut, 1999, 44(4):534-541
-
4Border WA, Noble NA, Yamamoto T,et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature, 1992, 360 (6402): 361-364
-
5Kruse ML, Hildebrand PB, Timke C, et al. TGFbeta1 au-tocrine growth control in isolated pancreatic fibroblastoid cells/stellate cells in vitro. Regul Pept, 2000, 90(1-3):47-52
-
6Haber PS, Keogh GW, Apte MV, et al. Activation of pancre-atic stellate cells in human and experimental pancreatic fibrosis.Am J Pathol, 1999, 155(4):1087-1095
-
7Schneider E, Schmid-Kotsas A, Zhao J, et al. Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol, 2001, 281(2): C532-543
-
8di Mola FF, Friess H, Martignoni ME, et al. Connective tis-sue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg, 1999, 231(1):63-71
-
9Vogelmann R, Ruf D, Wagner M, et al. Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-betal transgenic mouse model. Am J Physiol Gastrointest Liver Physiol, 2001, 280(1): G164-172
-
10Luttenberger T, Schmid Kotsas A, Menke A, et al. Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate Cells: implications in pathogenesis of pancreas fibrosis. Lab Invest, 2000, 80( 1 ): 47-55
共引文献10
-
1张汝玲,刘文滨,王兴鹏,吴恺,龚自华,吴丽颖,董育玮.1型血管紧张素Ⅱ受体拮抗剂对胰腺星状细胞的影响[J].中华消化杂志,2006,26(9):598-601. 被引量:2
-
2闫晶晶,崔乃强.慢性胰腺炎胰腺纤维化发病机制及其治疗的研究进展[J].中华肝胆外科杂志,2007,13(6):422-424. 被引量:2
-
3刘华生,陈馨馨,周景华.胰泰复方对慢性胰腺炎胰腺纤维化大鼠肿瘤坏死因子α(TNF-α)表达的影响[J].中华中医药学刊,2008,26(7):1378-1379. 被引量:3
-
4张利娜,徐世文.缺硒致胰腺损伤的研究进展[J].中国饲料,2008(21):7-10. 被引量:2
-
5田冰,陆建平,马超,杨根金,黄文才,汪剑,蒋斐,苏晓菊,王小玮.分辨魔角旋转核磁共振波谱在大鼠慢性胰腺炎分级中的应用[J].中华胰腺病杂志,2011,11(5):339-342.
-
6唐元瑜,水楠楠.油红O染色原代未活化胰腺星状细胞脂肪滴的实验观察[J].中国组织化学与细胞化学杂志,2013,22(3):266-268. 被引量:4
-
7张汝玲,王兴鹏,吴恺,龚自华,吴丽颖,董育玮,谢传高.胰腺星状细胞在胰腺癌组织中的激活及其可能作用[J].胰腺病学,2002,2(1):45-47. 被引量:3
-
8张汝玲,吴恺,龚自华,王兴鹏.三硝基苯磺酸(TNBS)诱导大鼠胰腺纤维化的病理学演变[J].胰腺病学,2002,2(3):136-140. 被引量:12
-
9王兴鹏,龚自华,吴凯,张汝玲.三硝基苯磺酸诱导大鼠慢性胰腺炎模型的建立[J].中华病理学杂志,2003,32(3):267-269. 被引量:5
-
10王兴鹏,张汝玲,龚自华,吴恺.胰腺星状细胞在大鼠胰腺纤维化形成中的作用[J].中华消化杂志,2003,23(8):466-469. 被引量:11
-
1林丽渊,吴晓东,沈文真.早期应用氧自由基清除剂治疗心肌炎[J].综合临床医学,1997,13(2):132-132.
-
2张利华,刘军,李波,杨欣国.依达拉奉治疗急性心肌梗塞的疗效观察[J].心血管康复医学杂志,2009,18(4):381-382. 被引量:4
-
3崔木平,王万平.氧自由基清除剂治疗病毒性肺炎疗效观察[J].皖南医学院学报,1998,17(4):385-386. 被引量:2
-
4徐志飞,蔡用之.氧自由基清除剂对兔心的保护作用[J].中华心血管病杂志,1989,17(5):305-308.
-
5王婷,常天才,岳卫平.氧自由基清除剂对急性肺损伤大鼠核因子-κB的作用及机制研究[J].中国当代医药,2013,20(26):10-11.
-
6刘彦君,许樟荣,张建中,李新元,崔学林,柏文田,赵德明,杨晋德,王玉珍.糖耐量减低的OLETF大鼠胰腺结构和功能改变与糖及脂代谢的关系[J].中华医学杂志,2000,80(3):175-177. 被引量:8
-
7王汉兵,王焱林,杨承祥.糖尿病周围神经病变疼痛机制研究进展[J].国际麻醉学与复苏杂志,2007,28(2):162-165. 被引量:11
-
8刘春同,王新月,陈霞,马西华.病毒性心肌炎102例治疗体会[J].菏泽医学专科学校学报,2005,17(1):38-39. 被引量:2
-
9常建国.慢性肝炎患者SOD含量变化及临床意义[J].苏州医学杂志,1996,19(2).
-
10廖兴志,熊源长.神经性疼痛机制在慢性胰腺炎中的作用[J].世界华人消化杂志,2009,17(31):3229-3232. 被引量:3